Biomarkers of Skeletal Muscle Atrophy Based on Atrogenes Evaluation: A Systematic Review and Meta-Analysis Study
Top Cited Papers
Open Access
- 9 April 2025
- journal article
- research article
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 26 (8)
Abstract
Muscle atrophy leads to decreased muscle mass, weakness, inactivity, and increased mortality. E3 ubiquitin ligases, key regulators of protein degradation via the ubiquitin–proteasome system, play a critical role in atrophic mechanisms. This meta-analysis followed Preferred Reporting Items for Systematic reviews and Meta-Analyses (PRISMA) guidelines, and its objective was to evaluate the association between E3 ligases Muscle Atrophy F-box (MAFbx)/Atrogin-1 (Fbxo32) and Muscle RING-finger protein 1 (MuRF-1) (TRIM63) E3 ligase mRNA levels, reductions in skeletal muscle CSA measures, and atrophy conditions. We examined papers published on PubMed®, Scopus, and Web of Science that studied E3 ligase gene expression signatures for Fbxo32 (MAFbx/Atrogin-1) and Trim63 (MuRF1) in different types of muscle atrophy and hypertrophy murine models. Twenty-nine studies selected by two independent raters were analyzed. Standardized mean differences (SMDs)/effect sizes (ESs) and 95% confidence intervals (CIs) were calculated for the outcomes using fixed-effects models. We found that 6- and 4.8-fold upregulation, respectively, of Fbxo32 and Trim63 was sufficient to reduce the ES to −3.89 (95% CI: −4.45 to −3.32) for the muscle fiber cross-sectional area and the development of skeletal muscle atrophy. I² and Q test statistics did not indicate heterogeneous data. There was a low probability of bias after both the funnel plot and Egger’s test analyses. These results were sustained independently of the atrophic model and muscle type. Therefore, the magnitude of the increase in muscle Fbxo32 and Trim63 mRNA is a feasible, reliable molecular marker for skeletal muscle atrophy in mice. The next step for the Ubiquitin-proteasome system (UPS) field involves elucidating the targets of E3 ligases, paving the way for diagnostic and treatment applications in humans.Keywords
Funding Information
- Conselho Nacional de Desenvolvimento Científico e Tecnológico (311700/2023-3, 201.180/2021)
- Fundação de Amparo à Pesquisa do Estado do Rio de Janeiro (311700/2023-3, 201.180/2021)
This publication has 63 references indexed in Scilit:
- Uncovering the mechanisms of MuRF1-induced ubiquitylation and revealing similarities with MuRF2 and MuRF3Biochemistry and Biophysics Reports, 2024
- Endoplasmic reticulum stress promotes sepsis‐induced muscle atrophy via activation of STAT3 and Smad3Journal of Cellular Physiology, 2023
- Neuron-derived neurotrophic factor protects against dexamethasone-induced skeletal muscle atrophyBiochemical and Biophysical Research Communications, 2022
- Progressive resistance exercise prevents muscle strength loss due to muscle atrophy induced by methylmercury systemic intoxicationJCSM Clinical Reports, 2021
- TNF Receptor-Associated Factor 6 Mediates TNFα-Induced Skeletal Muscle Atrophy in Mice During AgingJournal of Bone and Mineral Research, 2020
- Small‐molecule inhibition of MuRF1 attenuates skeletal muscle atrophy and dysfunction in cardiac cachexiaJournal of Cachexia, Sarcopenia and Muscle, 2017
- MG132-mediated inhibition of the ubiquitin–proteasome pathway ameliorates cancer cachexiaJournal of Cancer Research and Clinical Oncology, 2013
- Acupuncture ameliorated skeletal muscle atrophy induced by hindlimb suspension in miceBiochemical and Biophysical Research Communications, 2011
- The role and regulation of MAFbx/atrogin-1 and MuRF1 in skeletal muscle atrophyPflügers Archiv - European Journal of Physiology, 2011
- Mechanism and function of deubiquitinating enzymesBiochimica et Biophysica Acta (BBA) - Molecular Cell Research, 2004